Does SOTALOL Cause Ventricular hypertrophy? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Ventricular hypertrophy have been filed in association with SOTALOL (Sotalol). This represents 0.1% of all adverse event reports for SOTALOL.
5
Reports of Ventricular hypertrophy with SOTALOL
0.1%
of all SOTALOL reports
3
Deaths
4
Hospitalizations
How Dangerous Is Ventricular hypertrophy From SOTALOL?
Of the 5 reports, 3 (60.0%) resulted in death, 4 (80.0%) required hospitalization.
Is Ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOTALOL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does SOTALOL Cause?
Drug ineffective (412)
Electrocardiogram qt prolonged (324)
Accidental poisoning (294)
Bradycardia (238)
Atrial fibrillation (219)
Hypotension (208)
Toxicity to various agents (164)
Dyspnoea (152)
Dizziness (149)
Torsade de pointes (145)
What Other Drugs Cause Ventricular hypertrophy?
AMLODIPINE (46)
PREDNISONE (37)
PANTOPRAZOLE (36)
ASPIRIN (32)
VALSARTAN (29)
CLOZAPINE (28)
ACETAMINOPHEN (27)
TIOTROPIUM (24)
ALBUTEROL (21)
ONDANSETRON (21)
Which SOTALOL Alternatives Have Lower Ventricular hypertrophy Risk?
SOTALOL vs SOTATERCEPT
SOTALOL vs SOTATERCEPT-CSRK
SOTALOL vs SOTORASIB
SOTALOL vs SOTROVIMAB
SOTALOL vs SOVALDI